Episode 116: Renal cancer surgery controversi...

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions. 

This comprehensive podcast covers the latest advances in prostate, bladder, and kidney cancers from ASCO 2026, including new therapies, trial data, and practice-changing insights. Brian, Tom and Silke analyze recent studies, controversies, and future directions in GU oncology. 

Dr. Rachel Frank, Director of the Joint Preservation Program, Assistant Professor at the University of Colorado School of Medicine, and complex knee and shoulder surgeonContinue readingThe post Podcast on Use of Allografts and Orthobiologics in Orthopaedic Surgery appeared first ...  Show more

Quillette podcast host Jonathan Kay speaks with New York Times opinion columnist Ross Douthat about how his new book—which explores both his own fight against chronic Lyme disease, and the controversy surrounding the condition within the medical community 

JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.

Rela ...

Dr. Brian Cole shares tips for maintaining healthy joints, focusing on non-surgical and holistic remedies.